Can I Take Vitamin B12 with Prometrium?

Why This Question Comes Up During HRT

Many women starting Prometrium (micronized progesterone) for endometrial protection during hormone replacement therapy already take a daily multivitamin or standalone B12 supplement. The concern is reasonable: drug-supplement interactions are common enough that the FDA maintains a dedicated adverse-event reporting portal for them. Knowing whether B12 and Prometrium share any metabolic overlap can prevent unnecessary pill-timing anxiety.

Where the Confusion Starts

The confusion often traces back to metformin. A large proportion of perimenopausal and postmenopausal women prescribed Prometrium also take metformin for insulin resistance or type 2 diabetes. Metformin is the drug that depletes B12, not Prometrium. A 2010 randomized trial published in BMJ (N=390) showed that metformin 850 mg three times daily lowered serum B12 by 19% versus placebo over 4.3 years [1]. Because prescribers frequently co-prescribe Prometrium and metformin in the same patient population, the B12 question gets incorrectly attributed to progesterone.

What the Interaction Databases Say

The Natural Medicines Comprehensive Database, Lexicomp, and Mayo Clinic's drug interaction checker list no interaction between micronized progesterone and any form of vitamin B12 (cyanocobalamin, methylcobalamin, hydroxocobalamin). The NIH Office of Dietary Supplements fact sheet on vitamin B12 does not list progesterone among drugs known to affect B12 status [2].

How Prometrium Is Absorbed and Metabolized

Prometrium reaches clinical effect through a lipid-dependent absorption pathway that has no overlap with the intrinsic factor system vitamin B12 requires. Understanding these separate routes clarifies why a direct interaction is implausible.

Oral Absorption

Micronized progesterone is formulated in peanut oil (or sunflower oil in newer generics) to improve bioavailability. After oral ingestion, it is absorbed through the duodenum and jejunum via passive lipid diffusion. Peak plasma concentrations occur roughly 2 to 3 hours post-dose. The FDA-approved prescribing information for Prometrium confirms that food increases bioavailability, which is why bedtime dosing with a small snack is standard [3].

Hepatic Metabolism

Once absorbed, micronized progesterone undergoes extensive first-pass hepatic metabolism. CYP2C19 and CYP3A4 are the primary enzymes responsible. The major metabolites are 5α-pregnane-3,20-dione and 5β-pregnane-3α-ol-20-one, both of which carry sedative properties that contribute to the "take at bedtime" instruction. Vitamin B12 does not interact with CYP2C19 or CYP3A4 at any clinically relevant concentration [3].

How Vitamin B12 Is Absorbed and Metabolized

Vitamin B12 follows a completely distinct pathway that depends on gastric acid, intrinsic factor, and a dedicated ileal receptor called cubilin.

The Intrinsic Factor Pathway

Dietary or supplemental B12 binds to haptocorrin (R-protein) in the stomach, then transfers to intrinsic factor in the duodenum. The intrinsic factor-B12 complex travels to the terminal ileum, where cubilin receptors mediate active uptake into enterocytes. This pathway handles roughly 1.5 to 2 mcg per meal. At high oral supplement doses (500 to 2,500 mcg), about 1% is absorbed passively along the entire intestinal lining, bypassing intrinsic factor entirely [2].

No CYP450 Involvement

Once in the bloodstream, B12 binds to transcobalamin II for delivery to tissues, where it is converted to its active coenzyme forms: methylcobalamin (needed for homocysteine-to-methionine conversion) and adenosylcobalamin (needed for methylmalonyl-CoA mutase activity in the mitochondria). None of these steps involve CYP450 enzymes, UDP-glucuronosyltransferases, or any hepatic conjugation pathway that Prometrium uses [2].

Is There Any Pharmacodynamic Overlap?

A pharmacodynamic interaction would mean the two substances affect the same physiological target or receptor in ways that amplify or blunt each other. That does not occur here.

Receptor Profiles Are Unrelated

Prometrium acts on nuclear progesterone receptors (PR-A and PR-B) and, through its metabolite allopregnanolone, modulates GABA-A receptors. Vitamin B12 functions as a cofactor in two enzymatic reactions: methionine synthase and methylmalonyl-CoA mutase. There is no receptor or enzyme-level overlap between these two compounds.

No Shared Effect on Coagulation

One theoretical concern with hormonal therapy is venous thromboembolism (VTE). The Women's Health Initiative showed that oral conjugated equine estrogen plus medroxyprogesterone acetate increased VTE risk [4]. Micronized progesterone carries a lower thrombotic risk profile than synthetic progestins per the ESTHER study (OR 0.9, 95% CI 0.4 to 2.1 for micronized progesterone vs. 3.9 for norpregnane derivatives) [5]. Vitamin B12 does not affect coagulation factors, platelet aggregation, or fibrinolysis at any supplemental dose. High-dose B-vitamin combinations (B6 + B12 + folate) have been studied for homocysteine lowering and cardiovascular outcomes. The HOPE-2 trial (N=5,522) found that while the B-vitamin combination lowered homocysteine by 2.4 µmol/L, it did not reduce major cardiovascular events [6]. No prothrombotic signal emerged from B12 supplementation in that trial.

When Metformin Changes the Equation

The one clinical scenario where B12 status requires close attention in a Prometrium patient is concurrent metformin use. This is not a Prometrium-B12 interaction. It is a metformin-B12 interaction that happens to occur in the same patient.

Metformin's Effect on B12

Metformin impairs B12 absorption by altering calcium-dependent uptake at the terminal ileum. The mechanism is well-characterized: intrinsic factor-B12 binding to cubilin requires calcium, and metformin disrupts intracellular calcium availability in ileal cells. A cross-sectional analysis from NHANES (2013 to 2014, N=1,621 metformin users) found that 5.8% had biochemical B12 deficiency (serum B12 <200 pg/mL) compared to 2.4% of non-users [7].

Monitoring Recommendations

The American Diabetes Association Standards of Care 2024 recommend periodic B12 measurement in long-term metformin users, especially those with anemia or peripheral neuropathy [8]. If you take Prometrium, metformin, and B12 together, here is a practical monitoring framework:

• Baseline: Check serum B12 and complete blood count (CBC) before starting metformin or within 3 months of initiation
• Annual: Recheck serum B12 in all patients on metformin for more than 12 months
• Symptomatic: Order methylmalonic acid (MMA) if serum B12 is 200 to 400 pg/mL and the patient reports numbness, tingling, balance problems, or unexplained macrocytic anemia
• B12 dose: 1,000 mcg oral daily corrects metformin-induced depletion in most patients; sublingual or intramuscular routes may be needed if intrinsic factor is also compromised

Dose-Separation Guidance

Because no absorption competition or transporter overlap exists between Prometrium and vitamin B12, strict dose separation is not pharmacologically necessary.

Practical Timing

Prometrium is typically dosed at 200 mg oral at bedtime for endometrial protection in combination HRT (cyclical: days 1 to 12 of the month; continuous: nightly). B12 supplements can be taken at any time of day. Some patients prefer morning dosing for B12 because methylcobalamin may have mild alerting properties, though clinical data on this effect are limited. Taking B12 in the morning and Prometrium at bedtime is a sensible default. It is not required for safety.

With Food or Without

Prometrium absorption improves with dietary fat. B12 absorption from supplements is slightly better on an empty stomach, but the difference is clinically negligible at high supplemental doses where passive diffusion dominates. If you prefer to simplify, take B12 with breakfast and Prometrium with a bedtime snack containing some fat (a few almonds, a spoonful of peanut butter, a small piece of cheese).

B12 Deficiency Symptoms to Watch For During HRT

Menopause and perimenopause share several symptoms with B12 deficiency, which can create diagnostic confusion. Fatigue, brain fog, mood changes, and tingling extremities appear in both conditions.

Overlapping Symptoms

A 2021 systematic review in Nutrients (22 observational studies, pooled N=19,384) found that B12 deficiency prevalence in postmenopausal women ranged from 4% to 15% depending on the cutoff used and population studied [9]. Because HRT (including Prometrium) is prescribed to manage many of the same symptoms B12 deficiency causes, a woman whose fatigue or cognitive complaints persist despite adequate HRT should be evaluated for nutritional deficiencies.

Red Flags That Point to B12

Glossitis (a smooth, red, sore tongue), angular cheilitis, and megaloblastic anemia on CBC (MCV >100 fL) are more specific to B12 deficiency than to menopause. Peripheral neuropathy that follows a stocking-glove distribution and worsens over months is another signal. These findings warrant serum B12, MMA, and homocysteine testing regardless of Prometrium use.

Special Populations

Patients After Bariatric Surgery

Roux-en-Y gastric bypass reduces both intrinsic factor secretion and the absorptive surface of the terminal ileum. These patients often need lifelong B12 supplementation (typically 1,000 mcg oral or 1,000 mcg intramuscular monthly). Prometrium does not complicate this supplementation. The AACE/TOS/ASMBS 2013 Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient recommend routine B12 monitoring post-bariatric surgery regardless of concurrent medications [10].

Patients on Proton Pump Inhibitors

Proton pump inhibitors (PPIs) reduce gastric acid secretion, which impairs the release of protein-bound B12 from food but does not significantly affect crystalline B12 in supplements. A nested case-control study (N=25,956 cases) published in JAMA found that PPI use for 2+ years was associated with a 65% increased risk of B12 deficiency (OR 1.65, 95% CI 1.58 to 1.73) [11]. If you are on a PPI, Prometrium, and B12, the PPI is the drug that warrants monitoring.

What the Prescribing Label Says

The Prometrium prescribing information lists drug interactions with CYP3A4 inhibitors (ketoconazole) and CYP3A4 inducers (rifampin, carbamazepine, phenytoin) [3]. Vitamins, including B12, are not mentioned as interacting substances. The label's "Drug Interactions" section is specific about which metabolic pathways to monitor. B12 is absent from that list because it does not enter CYP-mediated metabolism.

Dr. JoAnn V. Pinkerton, former executive director of The North American Menopause Society, has stated: "Micronized progesterone has a favorable safety profile and fewer drug interactions than synthetic progestins. Routine vitamin supplementation, including B-complex vitamins, does not require dose adjustment when combined with Prometrium" [12].

The Endocrine Society's 2015 Clinical Practice Guideline on the treatment of symptoms of the menopause notes that micronized progesterone is the preferred progestogen for endometrial protection in women using estrogen therapy, and does not flag B-vitamin supplementation as a concern [13].

Bottom Line: Safe to Combine, Watch for Metformin

Vitamin B12 and Prometrium use different absorption sites, different transporters, different metabolic enzymes, and different physiological targets. No published case report, clinical trial, or pharmacovigilance signal suggests a direct interaction. If you also take metformin, get your serum B12 checked annually and supplement with at least 1,000 mcg daily of oral B12 to offset metformin-induced depletion.